Neurodegenerative diseases resulting from the progressive loss of structure and/or function
of neurons contribute to different paralysis degrees and loss of cognition and sensation. The …

Mesenchymal stem cells (MSCs) can differentiate into not only cells of mesodermal
lineages, but also into endodermal and ectodermal derived elements, including neurons …

Aim This article aims to study the benefits and disadvantages of stem cell therapy, especially
for patients who have dementia. Methods The databases PubMed, Google Scholar, and the …

At present, no effective cure or prophylaxis exists for Alzheimer's disease. Symptomatic
treatments are modestly effective and offer only temporary benefit. Advances in induced …

Alzheimer's disease (AD) is the sixth leading cause of death globally and the main reason
for dementia in elderly people. AD is a long-term and progressive neurodegenerative …

Alzheimer's disease (AD) is the most common progressive neurodegenerative disease
worldwide, but its cause remains unclear. Although a few drugs can provide temporary and …

Background Alzheimer's disease is a neurodegenerative disorder. Therapeutically, a
transplantation of bone marrow mesenchymal stem cells (BMMSCs) can play a beneficial …

Survivin is a protein functionally important for cell division, apoptosis, and possibly, for micro-
RNA biogenesis. It is an established marker of malignant cell transformation. In non …

The impact of human adult ischemia-tolerant mesenchymal stem cells (hMSCs) and factors
(stem cell factors) on cerebral amyloid beta (Aβ) pathology was investigated in a mouse …

Alzheimer's disease (AD) as a dementia and neurodegenerative disease, is mostly
prevalent among people more than 65 years. AD is mostly manifested in the form of …